Investorideas.com - Cannabis Stock News: Emerald Health Therapeutics (TSXV: EMH) (OTCQX: EMHTF) Launches New Fast-Acting Cannabis Spray Products Offering Consumers Significantly Improved Predictability and Control of Effects
www.investorideas.com - news that inspires big ideas
Monday, 31 August 2020
Friday, 28 August 2020
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) Announces Q2 2020 Results
Investorideas.com - Cannabis Stock News: Dixie Brands (CSE: DIXI.U) (OTCQX: DXBRF) Announces Q2 2020 Results
Join our Investor Club https://www.investorideas.com/membership/
Join our Investor Club https://www.investorideas.com/membership/
Thursday, 27 August 2020
Investorideas.com - Sonoma Valley Cannabis Enthusiasts Mourn and Celebrate
Investorideas.com - Sonoma Valley Cannabis Enthusiasts Mourn and Celebrate
www.investorideas.com - news that inspires big ideas
www.investorideas.com - news that inspires big ideas
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 461 (CSE: $TRUL.C) (OTC: $MJNA) (OTCQB: $WRHLF) (TSXV: $SUGR.V)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 461 (CSE: $TRUL.C)
(OTC: $MJNA) (OTCQB: $WRHLF) (TSXV: $SUGR.V)
Delta, Kelowna, BC, August 27, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/082720-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/08271TRUL-MJNA-WRHLF-SUGR.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few private and public company announcements.
Trulieve
Cannabis Corp. (CSE:
TRUL) (OTCQX:
TCNNF), a leading and top-performing cannabis company in the
United States, announced that it
will soon begin offering edible cannabis products to patients in Florida.
Following finalized regulations from the Florida Department of Health for the
sale of edible cannabis products and approval of its products, Trulieve will
introduce edibles in its medical cannabis dispensaries across the state,
expanding patient access to the types of products they have been requesting for
years.
Trulieve has planned for the debut
of edibles and, with the final guidelines in place from the Department of
Health (DOH), once its products are approved by the DOH, will be able to
introduce an exciting assortment of edible products.
In preparation for edibles rollout,
Trulieve built out a 10,000 sq. ft. commercial-grade kitchen at its production
facility in Quincy, FL, where Trulieve's skilled production team will produce
initial products as well as test and develop new offerings. In addition to its
branded product line, Trulieve has partnered with specialty edible brand
partners Binske, Bhang, District Edibles and Love's Oven to expand its edible
offerings to include cookies, brownies, and other products for Trulieve
customers.
"Similar to what we saw when
flower was introduced in 2019, we expect that edibles will contribute to a
sizable share of overall sales," said Kim Rivers, CEO of Trulieve.
"We know the demand is there, as we have been hearing from our customers
for some time now. To meet that pending demand, Trulieve was the first in the
Florida market to introduce ingestible products. We started with capsules and
extended to other forms, such as TruPowder in January, follow-on flavored
options just this month, and TruTincture Drops, which are similar to lozenges.
We are glad to finally be able to offer edibles as yet another option for
medical cannabis patients across Florida."
Rivers added, "We believe we
are well-positioned to meet the expected market demand for edibles, and believe
we are the only cannabis company in the state that can serve this variety
across 56 stores with not only our own Trulieve branded edibles, but also
robust product lines from partner brands."
Trulieve continues to build on
strong expansion and financial growth, recently reporting Q2 2020 revenue of
$120.8M and opening its 57th dispensary this week in Florida to serve nearly
400,000 patients in the state. Deemed an essential business, the company has
continued to operate throughout COVID-19 and expanded its employee base to meet
increased demand.
Medical
Marijuana, Inc. (OTC:
MJNA), the first-ever publicly traded cannabis company in
the United States that launched the world's first cannabis-derived
nutraceutical products, brands and supply chain, announced
today that the Company has reached a significant operational
milestone of selling and shipping more than 1.6 billion milligrams of hemp-based
cannabidiol (CBD) since 2017.
The Company’s milestone comes at a
time when e-commerce CBD sales have seen a sharp increase as four out of 10 CBD
consumers plan to use CBD oil more frequently during the COVID-19 pandemic and
15 percent of those consumers plan on using a higher dose of CBD than usual.
“For a decade, our Company has
offered the highest potency CBD product in an oral applicator form through our
flagship product, Real Scientific Hemp Oil™. We’ve seen international media
coverage of our customers having positive experiences with our products for
over half of a decade,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
“Many products on the market today use isolate forms of CBD, or contain no CBD
at all, marketing themselves as ‘hemp oil.’ While we are glad to have such high
demand for CBD products, we’re also proud to remain one of the highest quality
CBD oils on the market.”
As one of the pioneers of the
American hemp CBD industry, Medical Marijuana, Inc. has advocated for the compound
for over a decade and the Company’s products have remained popular among
consumers as mass awareness of CBD rapidly increases. Today, over 62 percent of
Americans recognize CBD and/or CBD products and about 33 percent of Americans
have used CBD at least once.
“We continue to believe in a world
where CBD and other cannabinoid-based products are a part of the general
population’s everyday wellness routine,” said Medical Marijuana, Inc. COO Blake
Schroeder. “While many new companies enter the hemp CBD space, our portfolio of
companies was the first to legally offer CBD products derived from industrial
hemp.”
World
High Life
(OTCQB:
WRHLF) acquired its wholly owned subsidiary, Love Hemp, less
than a year ago, and since securing the London-based CBD company, World High
Life continues to have that decision validated.
In 2020, Love Hemp has enjoyed a breakout year of consistently strong
growth, and the company recently
announced that it has once again posted impressive numbers, this
time for July 2020.
After reporting record financials in
the first two quarters of 2020 that led to a 107% increase in online sales from
January to May 2020, Love Hemp has continued that success to start the third
quarter. In July, the company reported a
57% growth in sales over corporate sales in June 2020. Additionally, Love Hemp said its online sales
remain significantly higher than pre-COVID-19 levels, which made up 62% of all
of the company’s sales in July compared to the 40% of sales registered in
January 2020.
Love Hemp is spearheading the
development of the United Kingdom’s (UK) leading range of trusted CBD products,
and its Chief Executive Officer (CEO), Tony Calamita, said of the continued
growth, “The wellness industry isn't showing any signs of slowing down. What we have witnessed is an increased
consumption of CBD during the pandemic, and we expect this to continue
post-COVID-19.”
In fact, the growth has been so
strong this year that Love Hemp has not only produced impressive sales results
month after month, but it is now expanding its operations to meet overwhelming
consumer demand. World High Life’s
subsidiary has started construction on a new multi-level 13,500-square-foot
facility that will increase production by more than five times its current
output across its entire range of CBD products, including oils, cosmetics, and
capsules.
The company announced that the new
facility, which should be completed in about six months, will increase its
daily on-site production from a limit of about 8,000 units of CBD oils,
cosmetics, and capsules currently, to in excess of, 43,000 units per day when
the project is completed in early 2021.
Love Hemp’s CEO commenting on the
expansion said, “This expansion further increases our capabilities in striving
to exceed customer and consumer requirements while improving storage and
production capabilities, lead times and ensuring the safety of our staff. Our strategy is to continue to expand our
local footprint, contributing to the future growth of our business, while also
providing quality CBD products to our consumers throughout the UK and around
the world.”
Expanding operations to increase
production output comes at just the right time as the company’s sales continue
to explode and as Love Hemp launched two new brands into the market this
year. Love Hemp has over 80 products,
including oils, sprays, edibles, cosmetics, and vapes, and the company
currently enjoys around 1,200 retail listings.
Calamita has always pointed to new product development, which is at the
heart of everything the company does, to stay on top of what consumers are
demanding more of from Love Hemp and the industry in general. “We currently have 15 new products in the
development stage, and we remain committed to creating the UK’s leading range
of trusted CBD products.”
In April, Love Hemp launched Love
Hemp Immune, a blend of CBD,
essential vitamins, including vitamins C and D, and bilberry extract to
maintain a healthy immune system by supporting our body’s natural defenses.
And, then in July, World High Life announced Love Hemp’s new brand, “Buzz
Leaf.”
The Buzz Leaf product line is aimed
at younger consumers that include the release of four broad spectrum CBD
infused e-liquids with added terpenes, and eventually the launch of a full
range of CBD products, including CBD oils and capsules. According to the company, the e-liquids
feature exotic flavors that contain 500mg of CBD.
Sugarbud
Craft Growers Corp. (TSXV:
SUGR) announced that,
as part of the previously announced contract manufacturing agreement, it has
formally started the final development and qualification of its additive-free,
full-spectrum vape cartridges with Heritage
Cannabis Holdings Corp. (CSE:
CANN).
Under the terms of the Agreement,
Heritage will continue to provide Sugarbud with extraction, formulation and
production services for the development of its pre-filled vape cartridges
utilizing proprietary, additive-free formulations.
"Our high quality,
additive-free, full-spectrum vape products contain dried cannabis as the sole
ingredient and are a natural and logical extension of our inhaled product
strategy. Sugarbud vape products will leverage and embody the quality,
consistency, flavour profiles and aromas found in our exceptional craft
cannabis flower," stated Mr. Kondrosky, CEO of Sugarbud.
New cannabis derivative products and
formats such as vape cartridges and pens are a rapidly growing segment of the
Canadian adult-use recreational market and Sugarbud expects that its
high-quality, additive-free vape products will become a significant catalyst
for future growth.
"We are confident that our
partnership with Heritage will equip Sugarbud to deliver high quality products
to consumers with the safety, integrity and exceptional outcomes they
demand," concluded Mr. Kondrosky.
"We are very pleased to be
working with Sugarbud on the production of full-spectrum vape cartridge
products to support its cannabis 2.0 strategy," commented Clint Sharples,
CEO of Heritage. "As Sugarbud's manufacturing partner, Heritage will
produce high-demand, full-spectrum cannabis oil products using no harmful
additives, flavours or carrier oils, and will maintain consistency in the
strain profile between Sugarbud's craft cannabis and the final products."
The Company expects to apply to
Health Canada for an amendment to its sales license to permit the direct sale
of cannabis extracts in early Q4 of 2020.
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and followers.
Contact management and IR of each company directly regarding specific
questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
Tuesday, 25 August 2020
Investorideas.com - Cannabis Stock News: THC (CSE: THC) (OTC: THCBF) Kiss Beverage Shot to Ship to Ontario's OCS - Pure Cannabis Sticks Available on Medical Site
Investorideas.com - Cannabis Stock News: THC (CSE: THC) (OTC: THCBF) Kiss Beverage Shot to Ship to Ontario's OCS - Pure Cannabis Sticks Available on Medical Site
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Get the latest Cannabis and Hemp stock news from www.investorideas.com
Monday, 24 August 2020
Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 459 (TSXV: $SUGR.V) (TSX: $AVCN.TO) (CSE: $THC.C) (CSE: $CHV.C) (CSE: $TTT.C)
Investor
Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 459 (TSXV: $SUGR.V)
(TSX: $AVCN.TO) (CSE: $THC.C) (CSE: $CHV.C) (CSE: $TTT.C)
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2020/082420-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2020/cannabis-potcasts/08241SUGR-AVCN-THC-CHV-TTT.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we look at a few public and private company announcements.
Sugarbud
Craft Growers Corp. (TSXV:
SUGR) announced that it
has received approval from Health Canada for its amended sales license
permitting the sale of dried cannabis products. Sugarbud is now able to
directly sell its portfolio of exceptional craft cannabis products to all
authorized provincial and territorial distributors/retailers as well as
registered medical patients.
"Today's announcement
represents yet another pivotal milestone for Sugarbud as we continue to scale
up our commercial activities and build overall shareholder value for the
Company," stated Sugarbud CEO, John Kondrosky. "Our amended Sales
License now gives us the ability to take direct control of our own sales and
marketing activities and further accelerate and expand the distribution of our
core Craft Cannabis Dried Flower and Pre-Roll products into new target
provinces - such as Alberta and British Columbia," continued Mr.
Kondrosky.
The Company estimates that less than
30% of all active federally approved license holders possess a sales license
permitting the sale of dried cannabis to authorized provincial and territorial
distributors/retailers as well as registered medical patients. "Receipt of our amended Sales License is
significant and was the result of a successful comprehensive inspection
process. It is a testament to our day-to-day operational readiness and
unwavering commitment to compliance as much as it is to the hard work, dedication
and passion that our employees continue to demonstrate each and every
day," concluded Mr. Kondrosky.
Sugarbud products are currently
available in the province of Saskatchewan under the terms and conditions of the
previously announced licensing and distribution agreement with Agro-Greens
Natural Products Ltd.
Avicanna
Inc. (TSX:
AVCN) (OTCQX:
AVCNF), a biopharmaceutical company focused on the
development, manufacturing and commercialization of plant-derived
cannabinoid-based products announced that
through its majority owned subsidiary, Santa Marta Golden Hemp S.A.S., the
company has completed exports of CBG and CBD isolates into the United States,
CBD isolate into Germany and the commencement of a pilot tracking system for
the export of its active pharmaceutical ingredient products in partnership with
TruTrace Technologies Inc. (CSE:
TTT)
(OTCQB:
TTTSF). The Company also announced that the Colombian
Ministry of Justice and Law has granted SMGH a commercial and industrial
cultivation quota for 12,264 THC plants by.
The export and sale of the
commercial lot of isolated CBG into the United States was completed in parallel
with commercial export of isolated CBD into the United States, as well as a
pilot export for R&D purposes of CBD into Germany. The cultivation,
extraction and purification of these cannabinoids including the rare cannabinoid,
CBG, were all completed through Avicanna's vertical integration at SMGH and
validate the company's innovation and leadership in natural rare cannabinoid
production. The products are part of the Aureus™ product portfolio that now
includes feminized seeds and advanced formulations as well as CBD, CBG and THC
API products.
"This is another massive
accomplishment for our team in Colombia as we enter the largest market in the
world for non-psychoactive cannabinoids with our proprietary CBG offering. As
the cannabinoid-derived products sector continues to evolve, our Aureus branded
portfolio continues to advance in order to cater to the needs of our cosmetics
and pharmaceutical partners, which require an innovative, credible,
thoroughly-tested, organic, sustainable and economical source of input
materials. Additionally, with the support of TruTrace, the Aureus products will
be provided with traceability and trackability all the way back to the seed
through a secured blockchain system." - Aras Azadian, Chief Executive
Officer of Avicanna.
The Colombian Ministry of Justice
and Law granted SMGH a supplementary cultivation quota to cultivate 12,264
psychoactive cannabis plants. 11,587 plants will be destined to produce dry
flower which will then be used to manufacture psychoactive derivatives for
commercial production for export. The remaining 677 plants will be utilized for
psychoactive derivatives for the purposes of research and development and pilot
production of Avicanna's RHO Phyto™ branded products in Colombia.
Lucas Nosiglia, President of
Avicanna LATAM commented: "This achievement took years of
characterization, evaluation and planning which will finally allow Avicanna to
produce our THC products and export THC derivatives to our international
partners. As one of the only companies permitted to produce THC commercially
for the global market, we can focus on less competitive and high margin
products."
THC
BioMed Intl Ltd. (CSE:
THC)
announced the
following updates:
THC BioMed announced that it has
received notice from the U.S. Patent and Trademark Office, that it has allowed
the patent application for THC's Clone Shipper Constant Illuminated,
Tamper-Resistant Plant Container. This is a successful end to the patent
application process. The next step will be the Issue Notification Letter to
come from the USPTO, which THC expects to receive approximately 3 weeks prior
to the official issuance date of the patent.
As noted in the title, this
container provides the plant inside it with a constant source of light and
helps plants do very well during shipping. The container is also
tamper-resistant, which is important for shipping plants such as cannabis
clones.
THC has also been focused on product
development and sales for "Cannabis 2.0," with edibles and beverages.
It has submitted the following new products to Health Canada for the 60-day
notice period for new products:
THC BioMed's latest product, THC
Kiss Gummies, are tasty gummy candies containing 2.5 mg of THC each. They will
come with 4 in a package (10 mg.) The cannabis extract used is from the same
proprietary extraction system as that used in THC Kiss beverage shot.
THC is also pleased to announce that
a new product, Kiss Water, has been submitted to Health Canada. THC Kiss Water is a refreshing beverage with a
slight herbal taste. Each 220 ml beverage contains 3 mg of THC.
THC chocolate has been formulated
with the same cannabis extract used is from the same proprietary extraction
system as that used in THC Kiss beverage shot and THC Kiss Gummies. The extract
is designed to be fast acting and uplifting and to provide a realistic and
great-tasting alternative to smoking cannabis.
Canada
House Wellness Group Inc. (CSE:
CHV)
announced
today that its wholly owned subsidiary, Abba Medix
Corp., has received its amended sales
license from Health Canada allowing for the sale of cannabis oil, concentrate,
topical and edible products produced from its facility in Pickering, Ontario.
The Company also announced that Abba
has entered into an agreement with Organic Extraction Technologies and is
currently employing equipment and services sourced from OET to produce
solventless cannabis rosin at its Pickering, Ontario facility.
This license amendment allows the
Company to further expand its existing product offerings to the medical and
recreational consumer markets with internally produced oil, concentrate,
extract, topical and edible products.
Abba is currently generating full-spectrum concentrates and will
continue to work closely with Canada House's wholly owned subsidiary, Canada
House Clinics ("CHC"), to
expand its portfolio of products to best manage the complex physical and psychological
conditions of its medical patient base.
"Receiving our Cannabis 2.0
sales license to allow for the sale of higher margin, internally produced
products represents another key milestone on Canada House's path to
profitability," said Chris Churchill-Smith, Canada House CEO. "Cannabis oil, rosin, and edibles are in
high demand, and we've been developing formulations to address the health and
wellness needs specifically as it relates to our Veteran patient base. This
license amendment will allow Abba to capture an even greater share of the over
$27M per year of medical products purchased by CHC's patients."
"It is a pleasure to work with
Abba's terrific team while implementing our technology in their top-notch
facility," commented Lindsay Labelle, CEO of Organic Extraction
Technologies. "Solventless extraction without chemicals or additives only
works with high quality cannabis. Our solventless products will allow us to
showcase some of the best flower and trim in the industry. We are excited to
bring the great genetics grown by Abba and its partners to market in new
full-spectrum formats."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Hear Investor ideas cannabis potcast on iTunes
Hear the investor ideas potcast on Spotify
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts and
videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy and more. Investor Idea’s original branded content includes
the following podcasts and columns : Crypto Corner , Play
by Play sports and stock news column, Investor Ideas
Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech
and Climate Change , Exploring
Mining the AI
Eye .
Disclaimer/Disclosure: Investorideas.com is a
digital publisher of third party sourced news, articles and equity research as
well as creates original content, including video, interviews and articles.
Original content created by investorideas is protected by copyright laws other
than syndication rights. Our site does not make recommendations for purchases
or sale of stocks, services or products. Nothing on our sites should be
construed as an offer or solicitation to buy or sell products or securities.
All investing involves risk and possible losses. This site is currently
compensated for news publication and distribution, social media and marketing,
content creation and more. Disclosure is posted for each compensated news
release, content published /created if required but otherwise the news was not
compensated for and was published for the sole interest of our readers and
followers. Contact management and IR of each company directly regarding
specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other
news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations
of each country. Please read Investorideas.com privacy policy:
https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more Cannabis Stock Investor Ideas – news,
articles, podcasts and
stock directory
Subscribe to:
Posts (Atom)
-
Investorideas.com - CBD Stock News: InnoCan Pharma (CSE: INNO) Announces the Successful Completion of an Independent Clinical Study Demonstr...
-
New #Cannabis Stocks Added to Investor Ideas; (TSX: $FAF.V) (CSE: $STIL.C) (CSE: $ORCD.C) (CSE: $VREO.C) (CSE: $PUMP.C) (OTC: $NUGL) ... -
Investor Ideas #Potcasts #Cannabis News and Stocks on the Move: Dixie Brands (CSE: $DIXI_U.C) (OTC: $DXBRF), Khiron Life Sciences (T...